VisEn Medical Selects Analogic for Fluorescence Molecular Tomography Systems

6/8/2004 - Analogic Corporation (NASDAQ: ALOG) announced that it has entered into an agreement to develop and manufacture innovative Fluorescence Molecular Tomography (FMT) imaging systems for VisEn Medical of Woburn, MA. FMT is part of the rapidly emerging field of molecular imaging, which enables molecular-level visualization of early-stage disease states and processes. FMT systems are being developed initially for drug development and research applications.

Lothar Koob, Executive Vice President of Analogic, noted current medical imaging modalities are used primarily to image later-stage disease morphologies. “Imaging at the molecular level represents a new paradigm for the way diseases are identified, evaluated, and managed. With Analogic’s considerable scientific and engineering resources, the Company is committed to advancing the frontiers of this emerging field. VisEn’s proprietary imaging agent and system technology platforms represent a breakthrough in the ability to image at the molecular level, both in animals and in humans. We look forward to working with VisEn in advancing this important new medical imaging technology.” Analogic has been developing technologies on the leading edge of medical imaging since it invented Instant Imaging Computed Tomography for an OEM customer some 30 years ago.

Guy Mayer, Chairman and CEO of VisEn, said, “Molecular optical imaging is rapidly establishing itself as a key pre-clinical and clinical imaging modality. We are thrilled to partner with Analogic, a recognized leader in the development of medical imaging components and systems, with a proven track record of reliability and performance. Analogic's expertise in imaging systems development, when combined with VisEn's strong market position in molecular agent and optical tomography platforms, will provide considerable benefit to our customers in the drug development and research communities."

Terms of the agreement were not disclosed.

VisEn Medical is developing proprietary imaging agent and optical tomography technology platforms that enable imaging at the molecular level, both in animals and in humans. The emerging field of molecular imaging enables molecular-level visualization of early-stage disease states and processes. The Company is focusing its development programs on the molecular imaging of diseases such as cancer, atherosclerosis, and rheumatoid arthritis. VisEn is headquartered in Woburn, Massachusetts. For further information please visit

Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, Cardiovascular Information Management, and Embedded Multicomputing. For further information visit

Previous Page | News by Category | News Search

If you found this page useful, bookmark and share it on: